Clinical trial
Growth Hormone's Effect on the Cardiovascular System
NCT00397319 · Vanderbilt University, Other · Terminated
Key facts
| NCT number | NCT00397319 |
|---|---|
| Title | Growth Hormone's Effect on the Cardiovascular System |
| Official title | The Role of Growth Hormone in Cardiovascular Health |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | Pfizer Industry National Center for Research Resources (NCRR) NIH |
| Status | Terminated |
| Study type | Observational |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Growth Hormone |
| Enrollment | 26 |
| Start date | Aug 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Nov 9, 2006 |
| Last update posted | Jul 3, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: